Vascular Biogenics Ltd (VBLT)

[Oren1976]

In recent presentation at Wainwright convention CEO said they can lead to 70% of patients to react with fever but they reach only 40% by killing the fever using corticosteroids and other fever killer drugs. This company keep making crucial mistakes that destroy their effective anti cancer drug. Right before he mentioned this fact he said we have 70% response rate in patients that react with fever. Moreover ,if you look at the data of the failed GLOBE phase 3 trial in gbm you will notice that febrile patients lived longer than control arm. If the people from VBL could induce fever in 70% of patients in GLOBE TRIAL we may have had a successful trial also in GBM